Keros Therapeutics, Inc. · NASDAQ:KROS
BlackRock, Inc. reported a 8.40% stake in Keros Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 8.40% stake in Keros Therapeutics, Inc., 1,671,343 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G/A).
- Stake
- 8.40%
- Shares
- 1,671,343
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 8.40% | 1,671,343 |
Source
Related
- Keros Therapeutics, Inc.
- BlackRock, Inc.
- Keros Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Apr 7, 2026
- Form 4 · Tanini Annita · Aug 20, 2026
- Form 4 · Lerner Lorena Raquel · Aug 20, 2026
- Form 4 · Cho Esther · Aug 20, 2026
- Form 4 · Newton Charles W. · Aug 20, 2026
- Form 4 · Bienaime Jean Jacques · Aug 19, 2026